RTX Corp: Form 10-Q for the period ended Sep 30, 2012
Filed with the SEC on Oct 26, 2012 and accepted by EDGAR at Oct 26, 2012, 11:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-07-01 to 2012-09-30 | $15.04bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2012-01-01 to 2012-09-30 | $41.27bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2012-07-01 to 2012-09-30 | $8.28bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2012-01-01 to 2012-09-30 | $21.72bn | us-gaap:CostOfGoodsSold |
| Research and development | 3 months2012-07-01 to 2012-09-30 | $590.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2012-01-01 to 2012-09-30 | $1.66bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2012-07-01 to 2012-09-30 | $1.62bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2012-01-01 to 2012-09-30 | $4.66bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-07-01 to 2012-09-30 | $2.04bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2012-01-01 to 2012-09-30 | $5.93bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2012-07-01 to 2012-09-30 | $484.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2012-01-01 to 2012-09-30 | $1.26bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-07-01 to 2012-09-30 | $1.42bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2012-01-01 to 2012-09-30 | $3.07bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-07-01 to 2012-09-30 | $1.56 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2012-01-01 to 2012-09-30 | $3.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-07-01 to 2012-09-30 | $1.58 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2012-01-01 to 2012-09-30 | $3.44 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-07-01 to 2012-09-30 | 907,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2012-01-01 to 2012-09-30 | 905,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2012-01-01 to 2012-09-30 | $4.65bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2012-01-01 to 2012-09-30 | $748.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2012-01-01 to 2012-09-30 | $1.29bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2012-01-01 to 2012-09-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2012-09-30 | $31.68bn | us-gaap:AssetsCurrent |
| Total assets | At period end2012-09-30 | $91.95bn | us-gaap:Assets |
| Current liabilities | At period end2012-09-30 | $26.45bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-09-30 | $65.62bn | us-gaap:Liabilities |
| Long-term debt | At period end2012-09-30 | $23.48bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2012-09-30 | $5.22bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2012-09-30 | $24.95bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2012-09-30 | 916,544,528 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-12-436499. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.